5 results
The primary objective is to evaluate the feasibility of early therapeutic effect evaluation by performing early follow up imaging after percutaneous MR-guided cryoablation of pT1a renal cell carcinoma. Secondary objective is to assess the outcomes…
1: determine the additional predictive value of MRI measures of brain connectivity on top of existing clinical parameters for cognitive recovery or deterioration in the first year after stroke.2: assess feasibility of a standardized work*up…
• Determine the maximum tolerated dose (MTD) and/or recommended dose (RD) for further evaluation of XL092 when administered alone and in combination with ICIs to subjects with advanced solid tumors• Evaluate preliminary efficacy of XL092 when…
Identification of MRI-based biomarkers to predict clinical outcome of major depressive disorder in comparison with healthy controls. Outcome is defined by level of depressive and cognitive symptomatology and related comorbidity.
Primary:Determine the MTD and/or RDE(s) of ABL001:* As a single agent for CML CP and AP patients* In combination with either nilotinib or imatinib or dasatinib in CML CP and AP patients* As a single agent for CML BP patients and Ph+ ALL…